Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gil I Wolfe

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Annals of Surgery|February 8, 2024
Effect of Lower Extremity Nerve Decompression in Patients With Painful Diabetic Peripheral Neuropathy: The Diabetic Neuropathy Nerve Decompression Randomized, Observation Group and Placebo Surgery-Controlled Clinical TrialShai M Rozen, Gil I Wolfe, Steven Vernino, et al.
Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.
Muscle & Nerve|October 4, 2002
Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravisGil I Wolfe, Richard J Barohn, Barbara M Foster, et al.
European Journal of Neurology|February 13, 2023
Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg studyMamatha Pasnoor, Vera Bril, Todd Levine, et al.
Neurology. Clinical Practice|December 20, 2018
Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy studyTodd D Levine, Jonathan S Katz, Richard Barohn, et al.
The Lancet. Neurology|January 25, 2025
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAli A Habib, Chongbo Zhao, Inmaculada Aban, et al.
Muscle & Nerve|November 3, 2009
Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experienceMamatha Pasnoor, Gil I Wolfe, Sharon Nations, et al.
Journal of the Peripheral Nervous System : JPNS|December 3, 2003
Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathyAlan R Berger, Walter G Bradley, Thomas H Brannagan, et al.
Neurology|May 6, 2018
Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRIKelly G Gwathmey, Reza Sadjadi, William B Horton, et al.
Annals of Neurology|March 13, 2008
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophyKathryn R Wagner, James L Fleckenstein, Anthony A Amato, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Annals of Surgery|February 8, 2024
Effect of Lower Extremity Nerve Decompression in Patients With Painful Diabetic Peripheral Neuropathy: The Diabetic Neuropathy Nerve Decompression Randomized, Observation Group and Placebo Surgery-Controlled Clinical TrialShai M Rozen, Gil I Wolfe, Steven Vernino, et al.
Neurology|July 1, 2016
International consensus guidance for management of myasthenia gravis: Executive summaryDonald B Sanders, Gil I Wolfe, Michael Benatar, et al.
Muscle & Nerve|October 4, 2002
Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravisGil I Wolfe, Richard J Barohn, Barbara M Foster, et al.
European Journal of Neurology|February 13, 2023
Phase 2 trial in acetylcholine receptor antibody-positive myasthenia gravis of transition from intravenous to subcutaneous immunoglobulin: The MGSCIg studyMamatha Pasnoor, Vera Bril, Todd Levine, et al.
Neurology. Clinical Practice|December 20, 2018
Review process for IVIg treatment: Lessons learned from INSIGHTS neuropathy studyTodd D Levine, Jonathan S Katz, Richard Barohn, et al.
The Lancet. Neurology|January 25, 2025
Safety and efficacy of satralizumab in patients with generalised myasthenia gravis (LUMINESCE): a randomised, double-blind, multicentre, placebo-controlled phase 3 trialAli A Habib, Chongbo Zhao, Inmaculada Aban, et al.
Muscle & Nerve|November 3, 2009
Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experienceMamatha Pasnoor, Gil I Wolfe, Sharon Nations, et al.
Journal of the Peripheral Nervous System : JPNS|December 3, 2003
Guidelines for the diagnosis and treatment of chronic inflammatory demyelinating polyneuropathyAlan R Berger, Walter G Bradley, Thomas H Brannagan, et al.
Neurology|May 6, 2018
Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRIKelly G Gwathmey, Reza Sadjadi, William B Horton, et al.
Annals of Neurology|March 13, 2008
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophyKathryn R Wagner, James L Fleckenstein, Anthony A Amato, et al.
Pageof 11